antgiorda : The limbo of having ER/PR low (<10%) is current • TwiCopy

Antonio Giordano, MD PhD

@antgiorda

+ Follow

Breast Medical Oncologist @harvardmed @DanaFarber driven by passion for #research and the one for taking care of #breastcancer patients #bcsm 🇮🇹🇺🇸

calendar_today31-05-2010 15:44:18

1,8K Tweets

2,5K Followers

1,0K Following

Antonio Giordano, MD PhD

@antgiorda

1 week ago

The limbo of having ER/PR low (<10%) is currently a very important problem for trial enrollment #BCSM #MBC
ER 0 PR 5% HER2 0
1⃣cannot be enrolled in HR+ cohorts if have not received CDK4/6i
2⃣cannot be enrolled in TNBC cohort because ASCO/CAP guidelines
FDA Oncology relax I/E cr

account_circle